The Journal of Organic Chemistry
Article
MHz, CDCl3), δ 211.5 (C, minor), 211.4 (C, major), 165.9 (C,
minor), 165.7 (C, major), 141.8 (C, major + minor), 128.6 (CH,
minor), 128.5 (CH, major), 128.2 (CH, minor), 128.0 (CH, major),
126.4 (CH, minor), 126.1 (CH, major), 100.4 (CH, minor), 100.2
(CH, major), 90.8 (CH, major + minor), 71.5 (CH, minor), 71.4 (CH,
major), 61.3 (CH2, minor), 61.1 (CH2, major), 14.2 (CH3, major +
minor).
C−C), 1252 (C−O−C), 1157 (C−O); 1H NMR (300 MHz, CDCl3)
δ 7.33 (t, 2H + 2H′, J = 8.5 Hz), 6.72 (d, 2H + 2H′, J = 8.2 Hz), 5.87
(m, 1H + 1H′), 5.70−5.84 (m, 1H + 1H′), 5.35 (m, 1H), 5.28 (m,
1H′), 4.14−4.27 (m, 2H + 2H′), 2.95 (s, 6H), 2.94 (s, 6H′), 2.35 (m,
1H + 1H′), 1.26−1.35 (m, 3H + 3H′); 13C NMR (75.5 MHz, CDCl3)
δ 211.33 (C), 211.26 (C), 165.8 (C), 165.6 (C), 150.7 (C), 150.6 (C),
129.48 (C), 129.42 (C), 127.6 (CH), 127.2 (CH), 112.5 (CH), 112.4
(CH), 100.5 (CH), 100.3 (CH), 91.0 (CH), 90.7 (CH), 71.3 (2 ×
CH), 61.04 (CH2), 60.98 (CH2), 40.59 (CH3), 40.57 (CH3), 14.3
(2 × CH3); found (FTMS + pNSI) [M + H]+ 262.1441, C15H20NO3
requires 262.1438.
Ethyl 5-(3,4-Dimethoxyphenyl)-5-hydroxypenta-2,3-dienoate
(3b).13 General procedure B was followed using 1-(3,4-
dimethoxyphenyl)prop-2-yn-1-ol to yield product 3b as a yellow oil
and a 1:1 mixture of diastereomers (325 mg, 0.90 mmol, 90%):
purified by column chromatography (eluent hexane/ethyl acetate, 10:1
to 7:1 to 5:1 to 3:1 to 2:1); Rf 0.29 (3:1 hexane/ethyl acetate);
νmax/cm−1 3474 br (OH), 2980 (C−H), 2836 (C−H), 1961 (CC,
allene), 1711 (CO), 1593, 1513, 1463, 1415 (Ar C−C), 1256
Ethyl 5-(4-tert-Butylphenyl)-5-hydroxypenta-2,3-dienoate (3f).
General procedure A was followed using 1-(4-(tert-butyl)phenyl)-
prop-2-yn-1-ol to yield product 3f as a yellow oil and a 1:1 mixture of
diastereomers (236 mg, 0.86 mmol, 63%): purified by column
chromatography (eluent hexane/ethyl acetate, 7:1 to 5:1); Rf 0.63
(hexane/ethyl acetate, 3:1); νmax/cm−1 3400 br (OH), 2962 (C−H),
1960 (CC, allene), 1713 (CO), 1509, 1463, 1408 (Ar C−C),
1
(C−O−C), 1138 (C−O); H NMR (300 MHz, CDCl3) δ 7.00 (m,
2H), 6.85 (d, 1H, J = 8.2 Hz), 5.88 (m, 1H), 5.78 (m, 1H), 5.36 (m,
1H), 4.20 (q, 2H, J = 7.1 Hz), 3.91 (s, 3H), 3.88 (s, 3H), 2.47 (br s,
1H), 1.28 (m, 3H); 13C NMR (75.5 MHz, CDCl3) δ 211.4 (C), 211.1
(C), 165.6 (C), 165.4 (C), 149.2 (C), 149.1 (C), 149.0 (C), 148.9
(C), 134.3 (C), 134.2 (C), 118.8 (CH), 118.5 (CH), 111.0 (CH),
110.9 (CH), 109.6 (CH), 109.3 (CH), 100.4 (CH), 100.2 (CH), 91.2
(CH), 90.8 (CH), 71.3 (CH), 71.2 (CH), 61.1 (CH2), 61.0 (CH2),
56.0 (2 × CH3), 14.2 (2 × CH3).
1
1254 (C−O−C), 1157 (C−O); H NMR (300 MHz, CDCl3) δ 7.39
(m, 4H + 4H′), 5.83−5.92 (m, 1H + 1H′), 5.77−5.80 (m, 1H), 5.74−
5.77 (m, 1H′), 5.37−5.43 (m, 1H), 5.31−5.37 (m, 1H′), 4.11−4.27
(m, 2H + 2H′), 3.07 (d, 1H′, J = 4.0 Hz), 2.96 (d, 1H, J = 4.1 Hz),
1.26−1.35 (m, 12H + 12H′); 13C NMR (75.5 MHz, CDCl3) δ 211.42
(C), 211.40 (C), 165.9 (C), 165.6 (C), 151.1 (C), 151.0 (C), 138.8
(C), 138.7 (C), 126.2 (CH), 125.9 (CH), 125.6 (CH), 125.5 (CH),
100.4 (CH), 100.2 (CH), 90.8 (CH), 90.7 (CH), 71.3 (CH), 71.2
(CH), 61.2 (CH2), 61.1 (CH2), 34.60 (C), 34.58 (C), 31.3 (2 ×
CH3), 14.2 (2 × CH3); found (FTMS + pNSI) [M + Na]+ 297.1458,
C17H22O3Na requires 297.1461.
Ethyl 5-Hydroxy-5-(2,4-dimethoxyphenyl)penta-2,3-dienoate
(3c). General procedure A was followed using 1-(2,4-dimethoxyphenyl)-
prop-2-yn-1-ol to yield product 3c as a yellow oil and a 1:1 mixture of
diastereomers (337 mg, 1.21 mmol, 89%): purified by column
chromatography (eluent hexane/ethyl acetate, 5:1 to 3:1); Rf 0.40 (3:1
hexane/ethyl acetate); νmax/cm−1 3400 br (OH), 3012 (C−H), 2836
(C−H), 1961 (CC, allene), 1704 (CO), 1588, 1505, 1464, 1416
(Ar C−C), 1260 (C−O−C), 1156 (C−O); 1H NMR (300 MHz,
CDCl3) δ 7.84 (d, 1H, J = 9.1 Hz), 7.27 (d, 1H′, J = 9.2 Hz), 6.42−
6.49 (m, 2H + 2H′), 5.99 (t, 1H, J = 6.0 Hz), 5.90 (t, 1H′, J = 6.0 Hz),
5.66−5.73 (m, 1H + 1H′), 5.52 (m, 1H + 1H′), 4.09−4.21 (m, 2H +
2H′), 3.81 (s, 3H + 3H′), 3.78 (s, 3H + 3H′), 3.31 (d, 1H, J = 6.4 Hz),
3.15 (d, 1H′, J = 6.4 Hz), 1.21−1.29 (m, 3H + 3H′); 13C NMR (75.5
MHz, CDCl3) δ 211.4 (C), 211.3 (C), 165.8 (C), 165.6 (C), 160.8
(C), 160.7 (C), 157.7 (C), 157.6 (C), 128.3 (CH), 128.0 (CH), 122.5
(2 × C), 104.34 (CH), 104.25 (CH), 99.8 (CH), 99.6 (CH), 98.7
(2 × CH), 90.7 (CH), 90.5 (CH), 67.7 (CH), 67.2 (CH), 60.9 (CH2),
60.8 (CH2), 55.43 (CH3), 55.39 (CH3), 14.23 (2 × CH3), 14.21
(2 × CH3); found (FTMS + pNSI) [M + Na]+ 301.1040, C15H18O5Na
requires 301.1046.
Ethyl 5-(Benzo[d][1,3]dioxol-5-yl)-5-hydroxypenta-2,3-dienoate
(3g). General procedure A was followed but on a smaller scale using
1-(benzo[d][1,3]dioxol-5-yl)prop-2-yn-1-ol (191.3 mg, 1.09 mmol,
1 equiv), CuI (10.2 mg, 0.05 mmol, 0.05 equiv), EDA (0.14 mL,
1.31 mmol, 1.2 equiv), and MeCN (1.1 mL) to yield product 3g as a
yellow oil and a 1:0.8 mixture of diastereomers (178 mg, 0.68 mmol,
63%): purified by column chromatography (eluent hexane/ethyl
acetate, 3:1); Rf 0.49 (3:1 hexane/ethyl acetate); νmax/cm−1 3400 br
(OH), 2982 (C−H), 1961 (CC, allene), 1709 (CO), 1502, 1487,
1441 (Ar C−C), 1241 (C−O−C), 1158 (C−O); 1H NMR (300
MHz, CDCl3) δ 6.96−6.98 (m, 1H′, minor), 6.94−6.96 (m, 1H,
major), 6.89−6.92 (m, 1H′, minor), 6.86−6.89 (m, 1H, major), 6.77
(s, 1H, major), 6.75 (s, 1H′, minor), 5.94 (s, 2H′, minor), 5.93 (s, 2H,
major), 5.79−5.86 (m, 1H + 1H′), 5.71−5.79 (m, 1H + 1H′), 9.29−
9.35 (m, 1H, major), 5.23−5.29 (m, 1H′, minor), 4.12−4.24 (m, 2H +
2H′), 3.25 (d, 1H′, J = 4.2 Hz, minor), 3.19 (d, 1H, J = 4.3 Hz, major),
1.24−1.33 (m, 3H + 3H′); 13C NMR (75.5 MHz, CDCl3) δ 211.4 (C,
major), 211.3 (C, minor), 165.9 (C, minor), 165.6 (C, major), 147.9
(C, minor), 147.8 (C, major), 147.5 (C, minor), 147.3 (C, major),
135.9 (C, major), 135.8 (C, minor), 120.0 (CH, minor), 119.6 (CH,
major), 108.11 (CH, minor), 108.07 (CH, major), 107.1 (CH, minor),
106.9 (CH, major), 101.13 (CH2, minor), 101.10 (CH2, major), 100.4
(CH, minor), 100.2 (CH, major), 91.0 (CH, minor), 90.7 (CH,
major), 71.22 (CH, minor), 71.21 (CH, major), 61.3 (CH2, minor),
61.2 (CH2, major), 14.2 (CH3, major + minor); found (FTMS +
pNSI) [M + Na]+ 285.0735, C14H14O5Na requires 285.0733.
Ethyl 5-(4-Bromophenyl)-5-hydroxypenta-2,3-dienoate (3h).
General procedure B was followed using 1-(4-bromophenyl)prop-2-
yn-1-ol to yield product 3h as an orange solid and a 1:1 mixture of
diastereomers (212 mg, 0.71 mmol, 60%): purified by column
chromatography (eluent hexane/ethyl acetate, 3:1); Rf 0.38 (3:1
hexane/ethyl acetate); mp 66−71 °C; νmax/cm−1 3400 br (OH), 2981
(C−H), 1962 (CC, allene), 1694 (CO), 1487, 1444 (Ar C−C),
1254 (C−O−C), 1159 (C−O); 1H NMR (300 MHz, CDCl3) δ 7.45−
7.51 (m, 2H + 2H′), 7.32−7.34 (m, 2H′), 7.28−7.32 (m, 2H), 5.80−
5.89 (m, 1H + 1H′), 5.73−5.78 (m, 1H + 1H′), 5.30−5.40 (m, 1H +
1H′), 4.11−4.25 (m, 2H + 2H′), 3.34 (d, 1H, J = 4.0 Hz), 3.17 (d,
1H′, J = 4.5 Hz), 1.17−1.41 (m, 3H + 3H′); 13C NMR (75.5 MHz,
CDCl3) δ 211.5 (2 × C), 165.8 (C), 165.5 (C), 140.7 (C), 140.6 (C),
131.7 (CH), 131.6 (CH), 128.1 (CH), 127.9 (CH), 122.0 (C), 121.9
(C), 100.1 (CH), 99.8 (CH), 91.0 (CH), 90.9 (CH), 70.90 (CH),
Ethyl 5-Hydroxy-5-(4-methoxyphenyl)penta-2,3-dienoate (3d).
General procedure A was followed using 1-(4-methoxyphenyl)prop-
2-yn-1-ol to yield product 3d as a yellow oil and a 1:1 mixture of
diastereomers (278 mg, 1.24 mmol, 78%): purified by column chro-
matography (eluent hexane/ethyl acetate, 3:1); Rf 0.33 (3:1 hexane/ethyl
acetate); νmax/cm−1 3426 br (OH), 2982 (C−H), 1961 (CC,
allene), 1711 (CO), 1511, 1489, 1443 (Ar C−C), 1245 (C−O−C),
1
1171 (C−O); H NMR (300 MHz, CDCl3) δ 7.36 (d, 2H, J = 8.8
Hz), 7.36 (d, 2H, J = 8.8 Hz), 6.87 (d, 2H, J = 8.6 Hz), 6.87 (d, 2H,
J = 8.7 Hz), 5.82−5.90 (m, 1H + 1H′), 5.74 (two overlapping t, 1H +
1H′, J = 5.7, 5.9 Hz), 5.36 (m, 1H), 5.30 (m, 1H), 4.12−4.25 (m,
2H + 2H′), 3.79 (s, 3H + 3H′), 3.28 (d, 1H, J = 3.6 Hz), 3.22 (d, 1H,
J = 3.8 Hz), 1.28 (m, 3H + 3H′); 13C NMR (75.5 MHz, CDCl3) δ
211.40 (C), 211.39 (C), 165.9 (C), 165.8 (C), 159.5 (C), 159.4 (C),
134.0 (C), 133.9 (C), 127.8 (CH), 127.5 (CH), 114.0 (CH), 113.8
(CH), 100.5 (CH), 100.3 (CH), 90.8 (CH), 90.6 (CH), 71.0 (2 ×
CH), 61.2 (CH2), 61.0 (CH2), 55.3 (2 × CH3), 14.2 (2 × CH3);
found (FTMS + pNSI) [M + Na]+ 271.0936, C14H16O4Na requires
271.0941.
Ethyl 5-(4-(Dimethylamino)phenyl)-5-hydroxypenta-2,3-dienoate
(3e). General procedure B was followed using 1-(4-(dimethylamino)-
phenyl)prop-2-yn-1-ol to yield product 3e as a red/orange oil and a
1:1 mixture of diastereomers (147 mg, 0.56 mmol, 39%): purified by
column chromatography (eluent hexane/ethyl acetate, 3:1); Rf 0.28
(3:1 hexane/ethyl acetate); νmax/cm−1 3400 br (OH), 2981 (C−H),
1959 (CC, allene), 1710 (CO), 1521, 1477, 1444, 1413 (Ar
1709
J. Org. Chem. 2015, 80, 1703−1718